Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Systematic Review: Evaluating the Prognostic Value of Granulomas in Crohn's Disease.
Journal: Digestive diseases and sciences
Published: April 21, 2026
Short Ileal Microvillus Length Phenotype Associates with Progression from Inflammatory to Complicated Disease Behavior in Pediatric Crohn's Disease.
Journal: Inflammatory bowel diseases
Published: September 23, 2025
Evaluation of pharmacokinetic metrics and pharmacodynamic biomarkers associated with endoscopic healing in pediatric Crohn's disease patients treated with anti-tumor necrosis factor biologics.
Journal: Crohn's & colitis 360
Published: August 05, 2025
Editorial: Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab.
Journal: Alimentary pharmacology & therapeutics
Published: January 13, 2025
A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas.
Journal: Scientific reports
Published: January 14, 2019
HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss.
Journal: PloS one
Published: January 06, 2017
FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance.
Journal: Oncotarget
Published: November 18, 2015
Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer.
Journal: Molecular cancer research : MCR
Published: April 17, 2014
Strain-specific suppression of microRNA-320 by carcinogenic Helicobacter pylori promotes expression of the antiapoptotic protein Mcl-1.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: October 19, 2013
FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies.
Journal: Oncotarget
Published: May 17, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026